Ticker Details
Aytu BioScience, Inc. Aytu BioScience Inc is engaged in acquiring, developing and commercializing products in the field of urology. It focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility.
IPO Date:	May 23, 2017
Sector:	Healthcare
Industry:	Pharma
Market Cap:	$24.69M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.08 | 3.84%
Avg Daily Range (30 D):	$0.06 | 2.52%
Avg Daily Range (90 D):	$0.07 | 2.84%

Institutional Daily Volume
Avg Daily Volume:	.11M
Avg Daily Volume (30 D):	.07M
Avg Daily Volume (90 D):	.08M

Trade Size
Avg Trade Size (Sh.):	32
Avg Trade Size (Sh.) (30 D):	157
Avg Trade Size (Sh.) (90 D):	191

Institutional Trades
Total Institutional Trades:	60
Avg Institutional Trade:	$1.63M
Avg Institutional Trade (30 D):	$.76M
Avg Institutional Trade (90 D):	$.76M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.59M
Avg Closing Trade (30 D):	$M
Avg Closing Trade (90 D):	$M
Avg Closing Volume:	20.99K

News

Jul 17, 2024 @ 11:03 AM Presenting on the Emerging Growth Conference 73 Da... Source: N/A

Nov 15, 2023 @ 7:04 PM Why Shapeways Holdings Shares Are Trading Lower By... Source: Lisa Levin

Sep 28, 2023 @ 5:04 PM Why CarMax Shares Are Trading Lower By Around 10%?... Source: Lisa Levin

Sep 28, 2023 @ 3:55 PM Best Penny Stocks? 4 Hot Stocks With News This Wee... Source: J. Samuel

Aug 9, 2023 @ 3:00 PM Benzinga's Top Ratings Upgrades, Downgrades For Au... Source: Benzinga Insights

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-1.05	$.21	$-3.18
Diluted EPS	$-1.05	$-.08
Revenue	$15.17M	$13.89M	$15.14M
Gross Profit	$9.62M	$9.19M	$10.25M
Net Income / Loss	$-10.58M	$1.97M	$-19.82M
Operating Income / Loss	$-1.97M	$-1.5M	$-7.62M
Cost of Revenue	$5.54M	$4.7M	$4.88M
Net Cash Flow	$-.93M	$M	$12.78M
PE Ratio

Splits
Jan 06, 2023	1:20
Dec 09, 2020	1:10
Aug 13, 2018	1:20
Aug 29, 2017	1:20
Jul 01, 2016	1:12
Jun 10, 2015	11:134